CanBas Co., Ltd. (4575.T)
JPY 1036.0
(-2.26%)
JPY 1036.0
(-2.26%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.26 Billion JPY | -30.65% |
| 2022 | -965.96 Million JPY | -14.12% |
| 2021 | -846.43 Million JPY | -54.55% |
| 2020 | -547.67 Million JPY | 3.37% |
| 2019 | -566.8 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q4 | -707.42 Million JPY | -323.1% |
| 2023 Q1 | -194.53 Million JPY | 26.94% |
| 2023 FY | -1.26 Billion JPY | -30.65% |
| 2023 Q3 | -167.2 Million JPY | 13.31% |
| 2023 Q2 | -192.87 Million JPY | 0.85% |
| 2022 Q2 | -238.46 Million JPY | 23.83% |
| 2022 FY | -965.96 Million JPY | -14.12% |
| 2022 Q4 | -266.27 Million JPY | -79.72% |
| 2022 Q3 | -148.15 Million JPY | 37.87% |
| 2022 Q1 | -313.07 Million JPY | 0.0% |
| 2021 FY | -846.43 Million JPY | -54.55% |
| 2020 FY | -547.67 Million JPY | 3.37% |
| 2019 FY | -566.8 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 311.453% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | -153.991% |
| GNI Group Ltd. | 13.1 Billion JPY | 109.627% |
| Linical Co., Ltd. | 725.72 Million JPY | 273.895% |
| Trans Genic Inc. | 89.43 Million JPY | 1511.065% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 11.498% |
| Soiken Holdings Inc. | -610 Million JPY | -106.883% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | -63.315% |
| AnGes, Inc. | -11.96 Billion JPY | 89.455% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | -12.598% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 86.752% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 1309.983% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | -45.995% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | -12.983% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | -58.035% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -274.076% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | -4.716% |
| Kidswell Bio Corporation | -1.33 Billion JPY | 5.51% |
| PeptiDream Inc. | 6.77 Billion JPY | 118.633% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 34.611% |
| Ribomic Inc. | -1.11 Billion JPY | -13.063% |
| SanBio Company Limited | -4.53 Billion JPY | 72.197% |
| Healios K.K. | -3.37 Billion JPY | 62.652% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | -9.257% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 9.437% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 10.05% |
| StemRIM | -2.07 Billion JPY | 39.21% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 203.316% |
| FunPep Company Limited | -994 Million JPY | -26.962% |
| Kringle Pharma, Inc. | -888.76 Million JPY | -41.995% |
| Stella Pharma Corporation | -760.3 Million JPY | -65.987% |
| TMS Co., Ltd. | -943.25 Million JPY | -33.792% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -62.757% |
| Cuorips Inc. | -588.48 Million JPY | -114.448% |
| K Pharma,Inc. | 366.05 Million JPY | 444.755% |
| Takara Bio Inc. | 3 Billion JPY | 142.025% |
| ReproCELL Incorporated | -409.29 Million JPY | -208.337% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 11507.394% |
| StemCell Institute Inc. | 413.75 Million JPY | 405.008% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 973.314% |
| CellSeed Inc. | -697.77 Million JPY | -80.86% |